Transforming Oncology
Advancing brain cancer treatment through pioneering research and transformative therapies for improved patient outcomes.
Our Focus
Our primary focus is on glioma, specifically glioblastoma multiforme (GBM), an aggressive and currently incurable form of brain cancer. With a deep understanding of the disease and a commitment to innovation, we aim to change the prognosis for patients suffering from this devastating condition. Discover more about glioblastoma multiforme and our approach to tackling it.
Learn More aboutOur Approach
The Blood-Brain Barrier is a natural defense that protects the brain from toxins and infections but has also stood as one of the greatest challenges in the treatment of glioblastoma and other CNS cancers, blocking many promising therapies from reaching the tumor. At CNS Pharmaceuticals, our technology is designed to potentially overcome this obstacle, enabling therapeutics to enter the brain and attack tumors. Learn more about how we're unlocking access to the brain.
Learn More aboutOur Pipeline
Our primary focus is on glioblastoma multiforme, an aggressive and currently incurable form of brain cancer. With a deep understanding of the disease and a commitment to innovation, we aim to change the prognosis for patients suffering from this devastating condition. Discover more about glioblastoma multiforme and our approach to tackling it.
Learn More aboutLatest News
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Read More of CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceIBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
Read More of IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Read More of CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateInvestor Relations
Explore our financial data and market performance. Get a clear picture of our strategic outlook.
Presentations
Access our comprehensive publications and presentations page for information on our research programs.
Email Alerts
Get timely updates on our latest developments. Subscribe to email alerts for new press releases, events and filings.
Pipeline
Track our ongoing research and development projects. Monitor the progress and future of our drug programs.